So our task at the university was to really
identify risks and share that with you and then minimize those risks so that you can
have a higher probability of success when you enter commercial production. We established
common field trial demonstrations, which we’ll go through. And then as an outcome, in our
hypothesis as you’ll see later, is that we feel that if we could show that there’s something
interesting in the plant, besides it being that it’s popular– nutritional benefits,
healthy benefits, medicinal application. We use a scientific application on purpose to
help generate interest by you as a grower. More importantly, if you’re not interested,
what interest by the consumer, buyer, and purchaser. We’ve done this through a lot of
other crops. I’ll give you some comparative studies as we go through. So the approach
was we looked at the top leading Puerto Rican, Mexican, we call those Latino populations.
Others call it Hispanic. Asian Indians and Chinese were evaluated. Fifty-six different
greens were looked at over a couple of years. Fourty-one crops were evaluated in the replicator
trials. Fifteen in demonstration plots across the 3 state areas. Replicator trial was set
up as a randomized block design with 3 replications. To the extent we were able to, whether personnel/staff
permitted, we did this in Florida, New Jersey, and Massachusetts. This summarizes the type
of studies we did over the course of a couple years. We will focus 2011 and 2012 data and
then looking particularly at amaranth, which we think is very promising for all the states.
We will get into that in a little more detail.